SVRA - Latest News
Savara Inc. (SVRA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $979.6M. Beta to the broader market is 0.25.
The article list below shows the most recent SVRA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent SVRA Headlines
Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026
businesswire.com - Oct 12, 2026
YARDLEY, Pa. --(BUSINESS WIRE)--Savara Inc.
BlackRock Inc. Takes $76.97 Million Position in Savara Inc. $SVRA
defenseworld.net - Aug 31, 2026
BlackRock Inc. acquired a new position in Savara Inc.
Algert Global LLC Purchases 464,645 Shares of Savara Inc. $SVRA
defenseworld.net - Aug 27, 2026
Algert Global LLC boosted its position in Savara Inc. (NASDAQ: SVRA) by 53.
Deutsche Bank AG Makes New $5.33 Million Investment in Savara Inc. $SVRA
defenseworld.net - Aug 25, 2026
Deutsche Bank AG purchased a new position in Savara Inc. (NASDAQ: SVRA) during the second quarter, according to its most recent 13F filing with the S
Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026
businesswire.com - Aug 24, 2026
YARDLEY, Pa. --(BUSINESS WIRE)--Savara Inc.
How News Affects SVRA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track SVRA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked SVRA news questions
- What is the latest SVRA news headline?
- The most recent SVRA headline (Oct 12, 2026) is "Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the SVRA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What SVRA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual SVRA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.